Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Response from PTSC IR on Shareholders meeting

A one time payment of a dividend would not need to go in a proxy, IMHO. We would need a vote if the co. is changing itself into something along the lines of an MLP, IMHO. As biajj has pointed out in the past---that may be the best route for the BoD to take. GL, ads

Share
New Message
Please login to post a reply